Patrick O'Brien
Equibles does not estimate personal net worth.
Get an email with a short summary when Arrowhead Pharmaceuticals, Inc. publishes a filing, an earnings call transcript or a press release.
Get ARWR alertsAbout Patrick O'Brien
Patrick O'Brien is recorded as COO at Arrowhead Pharmaceuticals, Inc. (ARWR) since July 15, 2022. Arrowhead Pharmaceuticals, Inc. reported in an 8-K filed July 20, 2022 that Patrick O'Brien was appointed Chief Operating Officer and General Counsel, effective July 15, 2022. Arrowhead Pharmaceuticals, Inc. is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at Arrowhead Pharmaceuticals, Inc. includes Christopher Anzalone (CEO and Board Member), Daniel Apel (CFO), Patrick O’Brien (COO and General Counsel) and 6 others.
“Arrowhead Pharmaceuticals, Inc. (the "Company") has appointed Patrick O'Brien, age 59, as Chief Operating Officer and General Counsel effective as of July 15, 2022.”
Affiliation history
-
Current
2022-07-15–present
Company network
Leadership on record at Arrowhead Pharmaceuticals, Inc.
- Christopher Anzalone CEO, Board Member
- Daniel Apel CFO
- Patrick O’Brien COO, General Counsel
- Douglas Ingram Board Member
- Dr. Matt Cohen, M.D., M.B.A. Board Member
- Hongbo Lu Board Member
- Hongbo Lu, Ph.D. Board Member
- Oye Olukotun, M.D., MPH Board Member
- Victoria Vakiener Board Member